ARTICLE | Clinical News
Becocalcidiol: Phase IIb data
June 20, 2005 7:00 AM UTC
In a double-blind, vehicle-controlled, U.S. Phase IIb in 185 patients showed that both the high- and low-dose becocalcidiol met the primary endpoint compared with vehicle. More than 5 times the number...